Immunotherapy Advances

eISSN: 2732-4303
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

SJR
Q4Mathematics (all)

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
Overview
  • Publisher
    Oxford University Press
  • Language
    English
  • Article Processing Charges
    GBP 2100
  • Publication Time
    7
  • Editorial Review Process
    Anonymous peer review
General Details
  • Language
    English
  • Society/Institute/Sponsor
    British Society for Immunology
  • Website URL
Publication Details
Editorial Review Detail
Information for authors
View less

Topics Covered

Antitumor response
Immune modulation
Clinical trial
VLA-4
Metabolic reprogramming
Antigen
B-cell lymphoma
Monoclonal antibody
Chimeric antigen receptor
Cancer immunotherapy
Steady state

Recently Published Papers

Year-wise Publication

FAQs

Who is the publisher of Immunotherapy Advances? Faqs

The publisher of Immunotherapy Advances is Oxford University Press.

How can I view the journal metrics of Immunotherapy Advances on editage? Faqs

For the Immunotherapy Advances metrics, please refer to the section above on the page.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Antitumor response, Immune modulation, Clinical trial, VLA-4, Metabolic reprogramming, Antigen, B-cell lymphoma, Monoclonal antibody, Chimeric antigen receptor, Cancer immunotherapy, Steady state.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.